Contraindications and Health Conditions PT-141 is not recommended for patients who: Have uncontrolled or poorly managed hypertension Are currently taking nitrate medications (due to risk of hypertensive crisis) Have a history of serious cardiovascular events (e.g., stroke, heart attack) Are pregnant, planning to become pregnant, or breastfeeding Have known hypersensitivity to bremelanotide or related peptides Additionally, patients with a history of severe allergic reactions, kidney or liver impairment, or complex neuroendocrine conditions should undergo comprehensive screening before starting PT-141
T., & Hazen, S
If you get an erection that lasts longer than a few hours, treat it as urgent
Full benefits typically develop over 8-12 weeks as your body adjusts to the medication
Meta-Analysis of Association between TCF7L2 Polymorphism Rs7903146 and Type 2 Diabetes Mellitus. BMC Medical Genetics, vol
then a 20 mg/kg dose (the typical therapeutic dose) produces a gut concentration of 6000 M, assuming 75% bioavailability